D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 146 Citations 83,612 1,371 World Ranking 502 National Ranking 18

Research.com Recognitions

Awards & Achievements

2015 - Fellow of the Australian Academy of Health and Medical Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Disease

Michael Berk mostly deals with Psychiatry, Bipolar disorder, Internal medicine, Depression and Schizophrenia. His studies in Psychiatry integrate themes in fields like Randomized controlled trial and MEDLINE. His work deals with themes such as Intervention, Mood disorders and Clinical psychology, Mood, which intersect with Bipolar disorder.

His research integrates issues of Endocrinology, Psychosis and Placebo-controlled study in his study of Internal medicine. His Depression research is multidisciplinary, relying on both Odds ratio, Mental health, Prospective cohort study, Risk factor and C-reactive protein. His study looks at the relationship between Schizophrenia and topics such as Pharmacology, which overlap with Adjunctive treatment.

His most cited work include:

  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. (988 citations)
  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. (988 citations)
  • Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors (807 citations)

What are the main themes of his work throughout his whole career to date?

Michael Berk mainly focuses on Psychiatry, Bipolar disorder, Internal medicine, Depression and Clinical psychology. His work on Psychiatry deals in particular with Mood, Schizophrenia, Major depressive disorder, First episode and Mental health. In his study, Clinical trial is strongly linked to Randomized controlled trial, which falls under the umbrella field of Bipolar disorder.

His biological study spans a wide range of topics, including Placebo, Endocrinology and Placebo-controlled study. His Depression research includes elements of Comorbidity, MEDLINE and Anxiety. As part of his studies on Clinical psychology, Michael Berk often connects relevant subjects like Cognition.

He most often published in these fields:

  • Psychiatry (60.27%)
  • Bipolar disorder (46.30%)
  • Internal medicine (37.51%)

What were the highlights of his more recent work (between 2018-2021)?

  • Bipolar disorder (46.30%)
  • Depression (28.94%)
  • Internal medicine (37.51%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Bipolar disorder, Depression, Internal medicine, Psychiatry and Randomized controlled trial. He specializes in Bipolar disorder, namely Mania. Michael Berk has researched Depression in several fields, including Mental health, Epidemiology, Disease and Anxiety.

His Internal medicine research incorporates elements of Placebo-controlled study, Placebo, Oncology and MEDLINE. Michael Berk conducts interdisciplinary study in the fields of Psychiatry and Clinical neurology through his research. His Randomized controlled trial research incorporates elements of Meta-analysis, Clinical trial and Adjunctive treatment.

Between 2018 and 2021, his most popular works were:

  • The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials (62 citations)
  • A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo (36 citations)
  • Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes. (34 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

Depression, Bipolar disorder, Internal medicine, Major depressive disorder and Mental health are his primary areas of study. His work carried out in the field of Depression brings together such families of science as Epidemiology, Disease, Bioinformatics and MEDLINE. Psychiatry covers Michael Berk research in Bipolar disorder.

The Major depressive disorder study combines topics in areas such as Guideline, Adverse effect, Dementia and Clinical psychology. Michael Berk works mostly in the field of Mental health, limiting it down to topics relating to Public health and, in certain cases, Reciprocity, Social environment, Gerontology and Urbanization. His Schizophrenia research integrates issues from Adjunctive treatment, Psychosis, Cognition, Neuroprotection and Autism spectrum disorder.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

Michael Berk;Flavio P Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;Olivia Dean;Olivia Dean.
Neuroscience & Biobehavioral Reviews (2011)

1062 Citations

Oxidative stress in psychiatric disorders : evidence base and therapeutic implications

Felicity Ng;Michael Berk;Michael Berk;Olivia Dean;Ashley I. Bush.
The International Journal of Neuropsychopharmacology (2008)

1022 Citations

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

Lakshmi N. Yatham;Sidney H. Kennedy;Sagar V. Parikh;Ayal Schaffer.
Bipolar Disorders (2013)

988 Citations

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

Michael Maes;Piotr Galecki;Yong Seun Chang;Michael Berk;Michael Berk.
Progress in Neuro-psychopharmacology & Biological Psychiatry (2011)

958 Citations

So depression is an inflammatory disease, but where does the inflammation come from?

Michael Berk;Lana Williams;Lana Williams;Felice N Jacka;Felice N Jacka;Adrienne O'Neil;Adrienne O'Neil.
BMC Medicine (2013)

926 Citations

Association of Western and Traditional Diets With Depression and Anxiety in Women

Felice N Jacka;Julie A Pasco;Arnstein Mykletun;Lana J Williams.
American Journal of Psychiatry (2010)

741 Citations

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

Lakshmi N Yatham;Sidney H Kennedy;Ayal Schaffer;Sagar V Parikh.
Bipolar Disorders (2009)

623 Citations

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

Lakshmi N Yatham;Sidney H Kennedy;Sagar V Parikh;Ayal Schaffer.
Bipolar Disorders (2018)

623 Citations

The chemistry and biological activities of N-acetylcysteine

Yuval Samuni;Sara Goldstein;Olivia M. Dean;Olivia M. Dean;Olivia M. Dean;Michael Berk.
Biochimica et Biophysica Acta (2013)

619 Citations

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)

584 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael Berk

Eduard Vieta

Eduard Vieta

University of Barcelona

Publications: 354

Gin S Malhi

Gin S Malhi

University of Sydney

Publications: 229

Roger S. McIntyre

Roger S. McIntyre

University Health Network

Publications: 213

Michael Maes

Michael Maes

Chulalongkorn University

Publications: 212

Flávio Kapczinski

Flávio Kapczinski

McMaster University

Publications: 197

André F. Carvalho

André F. Carvalho

Centre for Addiction and Mental Health

Publications: 181

João Quevedo

João Quevedo

The University of Texas Health Science Center at Houston

Publications: 153

Brendon Stubbs

Brendon Stubbs

King's College London

Publications: 137

Patrick D. McGorry

Patrick D. McGorry

University of Melbourne

Publications: 126

Allan H. Young

Allan H. Young

South London and Maudsley NHS Foundation Trust

Publications: 115

Lakshmi N. Yatham

Lakshmi N. Yatham

University of British Columbia

Publications: 114

Jan Scott

Jan Scott

Newcastle University

Publications: 103

Marion Leboyer

Marion Leboyer

Paris-Est Créteil University

Publications: 102

Michael Bauer

Michael Bauer

TU Dresden

Publications: 101

Brenda W.J.H. Penninx

Brenda W.J.H. Penninx

Vrije Universiteit Amsterdam

Publications: 96

Lars Vedel Kessing

Lars Vedel Kessing

University of Copenhagen

Publications: 94

Something went wrong. Please try again later.